InfertilityNCT03240276
A Comparative Study of Sibling Oocytes: ICSI vs. the IMSI Sperm Selection Method
A study testing Standard ICSI procedure for sperm injection into oocyte, MSOME and IMSI Procedure in people with Infertility, run by Hillel Yaffe Medical Center at 1 site in Israel.
Trial summary
The aim of this research is to compare sibling oocytes using two sperm selection methods for choosing the best quality spermatozoa before they are injected into oocytes and the influence of each of these methods on embryo quality and IVF outcome. Read more about this study
- Who is it for?
- Ages 18 to 60 years
- Conditions the study is for
- Infertility
- What is being tested?
- Standard ICSI procedure for sperm injection into oocyte, MSOME and IMSI Procedure
- Type of treatment
- Injection or infusion, Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 50 participants
- Where
- 1 siteIsrael
- Study dates
- Sep 2017to Sep 2020
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 60 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Males aged 18-60
- Females aged 18-35
- Males defined as Moderate OTA or Isolated Teratozoospermia with less than 4% morphologically normal spermatozoa
- Patients with 0.5- 7% normal sperm according to MSOME analysis
- Females with normal FSH and AMH values
- Females who have retrieved at least 6 oocytes in previous cycles
- Couples who have had at least 2 failed IVF-ICSI cycles
Who cannot join
- Couples who have been exposed to heavy smoking, drugs and chronic diseases
- Males who have undergone testicular surgery (TESE) or defined as severe OTA
- Females with egg factor infertility
Trial locations and contacts
1 site in 1 country.
Israel1 site
Hillel Yaffe Medical Center
Hadera, 38100
Medeia Michaeli, PhD, 972-50-6246885, medeia.michaeli@gmail.com
About this study
Official title: A Comparative Study of Sibling Oocytes, Which Examines Two Sperm Selection Methods for Top Quality of Spermatozoa , Prior Intracytoplasmic Sperm Injection (ICSI) Performance, and Their Effect on Embryo Quality and IVF Outcome: A Common Selection Method Based on Morphology (ICSI) vs. an Ultra Morphology Section Method - Intracytoplasmic Morphology Selected Sperm Injection (IMSI)
The aim of this research is to compare sibling oocytes using two sperm selection methods for choosing the best quality spermatozoa before they are injected into oocytes and the influence of each of these methods on embryo quality and IVF outcome.
- Conditions
- Infertility
- Being tested
- Standard ICSI procedure for sperm injection into oocyte, MSOME, IMSI Procedure
- Medical subject headings
- Infertility
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Standard ICSI procedure for sperm injection into oocyteOther
The ICSI procedure is the standard procedure of selection and injection of sperm into oocytes
MSOMEDevice
Also called Motile Sperm Organelle Morphology Examination
Selection of ultramorphologically normal spermatozoa using an inverted microscope with 6300x magnification
IMSI ProcedureOther
Injection of sperm that has been selected by the MSOME method into oocytes
| Study group | Role | What they receive |
|---|---|---|
| ICSI Procedure | Active comparator | The ICSI procedure is the standard procedure of selection and injection of sperm into the oocyte Receives: Other: Standard ICSI procedure for sperm injection into oocyte |
| IMSI Procedure | Active comparator | The IMSI procedure is the injection of normal ultramorphological spermatozoa that have been selected using an inverted microscope with magnification of 6300x (MSOME) Receives: Device: MSOME; Other: IMSI Procedure |
What is being measured
The primary outcome is the main question the study is designed to answer.
Comparison of fertilization rate
Injected sibling oocytes are incubated in a time-lapse incubator which enables ongoing observation after fertilization and cleavage of each oocyte. The fertilization rates of the ICSI and IMSI methods will be compared.
Measured: Three years
Comparison of embryo quality
Injected sibling oocytes are incubated in a time-lapse incubator which enables ongoing observation after fertilization and cleavage of each oocyte. The embryo quality of the ICSI and IMSI methods will be compared.
Measured: Three years
Secondary outcomes (4)
Implantation rate
Injected sibling oocytes are incubated in a time-lapse incubator which enables ongoing observation after fertilization and cleavage of each oocyte. The implantation rates of the ICSI and IMSI methods will be compared.
Measured: Three years
Pregnancy rate
Injected sibling oocytes are incubated in a time-lapse incubator which enables ongoing observation after fertilization and cleavage of each oocyte. The pregnancy rates of the ICSI and IMSI methods will be compared.
Measured: Three years
Miscarriage rate
Injected sibling oocytes are incubated in a time-lapse incubator which enables ongoing observation after fertilization and cleavage of each oocyte. The miscarriage rates of the ICSI and IMSI methods will be compared.
Measured: Three years
Live birth rate
Injected sibling oocytes are incubated in a time-lapse incubator which enables ongoing observation after fertilization and cleavage of each oocyte. The live birth rates of the ICSI and IMSI methods will be compared.
Measured: Three years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Aug 2017
- Study startSep 2017 (estimated)
- Primary completionSep 2020 (estimated)
- Study completionSep 2020 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for InfertilityStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 50 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Hillel Yaffe Medical Center
- Sponsor type
- Other government
- Responsible party
- Sponsor
- Investigators
- Einat Shalom Paz, MD, Principal investigator, Hillel Yaffe Medical CenterMedeia Michaeli, PhD, Study director, Hillel Yaffe Medical Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03240276
- Sponsor's protocol ID
- HYMC-0070-17
- Status last verified
- Aug 2017
- First submitted
- 31 Jul 2017
- Last updated
- 7 Aug 2017
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 7 Aug 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Comparative Study of Sibling Oocytes, Which Examines Two Sperm Selection Methods for Top Quality of Spermatozoa , Prior Intracytoplasmic Sperm Injection (ICSI) Performance, and Their Effect on Embryo Quality and IVF Outcome: A Common Selection Method Based on Morphology (ICSI) vs. an Ultra Morphology Section Method - Intracytoplasmic Morphology Selected Sperm Injection (IMSI)
- ClinicalTrials.gov ID
- NCT03240276
- Acronym / sponsor ID
- HYMC-0070-17
- Conditions
- Infertility
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 50 participants (estimated)
- Lead sponsor
- Hillel Yaffe Medical CenterOther government
- Study start
- Sep 2017 (estimated)
- Primary completion
- Sep 2020 (estimated)
- Study completion
- Sep 2020 (estimated)
- First posted
- 7 Aug 2017 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this research is to compare sibling oocytes using two sperm selection methods for choosing the best quality spermatozoa before they are injected into oocytes and the influence of each of these methods on embryo quality and IVF outcome.
Study design
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| ICSI Procedure | Active comparator | Other: Standard ICSI procedure for sperm injection into oocyteThe ICSI procedure is the standard procedure of selection and injection of sperm into the oocyte |
| IMSI Procedure | Active comparator | Device: MSOME, Other: IMSI ProcedureThe IMSI procedure is the injection of normal ultramorphological spermatozoa that have been selected using an inverted microscope with magnification of 6300x (MSOME) |
Who may qualify
- Ages
- 18 to 60 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (7 listed)
- Males aged 18-60
- Females aged 18-35
- Males defined as Moderate OTA or Isolated Teratozoospermia with less than 4% morphologically normal spermatozoa
- Patients with 0.5- 7% normal sperm according to MSOME analysis
- Females with normal FSH and AMH values
Key exclusion criteria (3 listed)
- Couples who have been exposed to heavy smoking, drugs and chronic diseases
- Males who have undergone testicular surgery (TESE) or defined as severe OTA
- Females with egg factor infertility
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Standard ICSI procedure for sperm injection into oocyteThe ICSI procedure is the standard procedure of selection and injection of sperm into oocytes | Other | ICSI Procedure |
| MSOMEAlso: Motile Sperm Organelle Morphology ExaminationSelection of ultramorphologically normal spermatozoa using an inverted microscope with 6300x magnification | Device | IMSI Procedure |
| IMSI ProcedureInjection of sperm that has been selected by the MSOME method into oocytes | Other | IMSI Procedure |
Primary outcome
Comparison of fertilization rate
Time frame: Three years
Injected sibling oocytes are incubated in a time-lapse incubator which enables ongoing observation after fertilization and cleavage of each oocyte. The fertilization rates of the ICSI and IMSI methods will be compared.
Comparison of embryo quality
Time frame: Three years
Injected sibling oocytes are incubated in a time-lapse incubator which enables ongoing observation after fertilization and cleavage of each oocyte. The embryo quality of the ICSI and IMSI methods will be compared.
4 secondary outcomes
Implantation rate
Time frame: Three years
Pregnancy rate
Time frame: Three years
Miscarriage rate
Time frame: Three years
Live birth rate
Time frame: Three years
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Aug 2017.
- Individual participant dataSharing planned: No
Related trials for Infertility
RecruitingPhase 3
A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA)
Infertility
Active, not recruitingObservational study
Fresh Versus Vitrified-Warmed Donor Oocytes: Embryological and Clinical Outcomes
Infertility, Donor Oocyte Assisted Reproduction
RecruitingObservational study
Safety and Efficacy of Corifollitropin Alfa N02 Injection in Elderly Women Undergoing Assisted Reproductive Technology (ART)
Infertility
Active, not recruiting
Automation of the In Vitro Fertilization Laboratory
Infertility, ART
Not yet recruiting
Implementing IVM for Fertility Treatment in Clinical Practice
Infertility
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Einat Shalom Paz, MD principal investigator
Hillel Yaffe Medical Center
Medeia Michaeli, PhD study director
Hillel Yaffe Medical Center
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Standard ICSI procedure for sperm injection into oocyte, MSOME and IMSI Procedure in people with Infertility, run by Hillel Yaffe Medical Center at 1 site in Israel.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 7 Aug 2017. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Medeia Michaeli, PhD (972-50-6246885, medeia.michaeli@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Comparison of fertilization rate (time frame: Three years). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Aug 2017.